Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Biotechnology > Genome-based Drug Discovery > U.S. Microfluidics/Lab-on-a-chip Markets
Category
Biotechnology (1524)
Antibody & Immunity (193)
Biomarker (169)
Biomaterials (56)
Biotechnology Equipment (348)
Gene Therapeutics & RNAi (104)
Genome-based Drug Discovery (204)
Molecular Targeted Therapeutics (51)
Personalized Medicine (57)
Regenerative Medicine (122)
Market Research Report

U.S. Microfluidics/Lab-on-a-chip Markets

Published by Frost & Sullivan
Published May, 2006 Product code 41941
Content info 555 pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


U.S. Microfluidics/Lab-on-a-chip Markets published by Frost & Sullivan in May, 2006. This report consists of 555 pages and the price starts from US $ 6000.

Introduction

Abstract

This Frost & Sullivan research service titled U.S. Microfluidics/Lab-on-a-chip Markets provides a complete market analysis and revenue forecasts. In this research service, Frost & Sullivan' s expert analysts thoroughly examine the following markets/applications/technologies: DNA/RNA, protein, and cell-based microfluidics.

Table of Contents

1 EXECUTIVE SUMMARY

  • Market Overview
    • Introduction

2 TOTAL MICROFLUIDICS/LAB-ON-A-CHIP MARKETS

  • Market Overview
    • Introduction
    • Scope and Segmentation
    • Research Methodology
    • Market Engineering Analysis
  • Market Drivers and Restraints
    • Market Drivers
    • Market Restraints
  • Market Challenges and Strategic Recommendations
    • Industry Challenges
    • Strategic Recommendations
  • Market Trends and Forecasts
    • Market and Technology Trends
    • Revenue Forecasts
  • Competitive Analysis
    • Competitive Structure
    • Market Share Analysis
    • Product Analysis
  • Frost and Sullivan Awards
    • Product Innovation Award
    • Technology Leadership Award

3 APPENDIX

  • Decision Support Database
    • Number of Biotechnology Companies
    • Government R&D Investment in Biotechnology
    • Private Investment in Biotechnology
    • Total Healthcare Expenditure
    • Pharmaceutical R&D Expenditure
Back to Top